All About SGLT Inhibitors for T1D

SGLT inhibitors are oral medications that work by decreasing the production of transport proteins and reducing the absorption of glucose by the intestines and kidneys respectively. Up until now, these drugs have been used exclusively by those with Type 2 diabetes. Inhibitors on the market currently include SGLT-2 inhibitors Farxiga and Jardiance, and Zynquista, the first dual SGLT-1 and SGLT-2 inhibitor.

Senseonics Suspends Commercial US Sales of Eversense in Response to COVID-19

On March 26, Senseonics suspended all commercial sales of the Eversense continuous glucose monitor (CGM) in the United States.

Beyond Type 1 Joins Smarter Healthcare Coalition (SHCC) in Urging Congress to Expand Telehealth Coverage

On March 20, Beyond Type 1 signed a letter to Congress penned by the Smarter Healthcare Coalition, urging the broadening of telehealth coverage for COVID-19.

Dexcom G7 Updates with CEO Kevin Sayer

Dexcom CEO Kevin Sayer discusses Dexcom’s international strategy, the next-generation Dexcom G7, and the response to the Dexcom Follow outage last Fall.

The Diabetes Disaster Response Coalition Coronavirus Response

On March 12, the Diabetes Disaster Response Coalition (DDRC) circulated an update to coalition members in response to coronavirus (COVID-19). Here are the steps the organization is taking and other important information to note.

New Medicare Plan Will Cap Insulin Copays at $35

On March 11, the Centers for Medicare & Medicaid Services (CMS) launched a new plan for some Medicare Part D participants to pay a maximum $35 copay for their monthly supply of insulin.

Omnipod Closed Loop Technology to be Compatible with both Abbott and Dexcom CGMs

Abbott and Dexcom announced formal partnerships with Insulet to be compatible as CGMs on the Omnipod Horizon Automated Insulin Delivery System. 

FDA Issues Class I Recall of Certain Medtronic Insulin Pumps

The FDA announced Wednesday that it has issued a Class 1 recall of Medtronic MiniMed 600 Series insulin pumps, after reports of 2,175 injuries and 1 death.

Coronavirus (COVID-19) and Diabetes – What You Should Know

A helpful breakdown of what people with diabetes should know about the Coronavirus that's been making headlines since first reports of it emerged in China earlier this year.

New Evidence Shows Vital Importance of Screening For T1D in Children

By screening for Type 1 diabetes in children, Bavaria was able to decrease rates of diabetic ketoacidosis at diagnosis.

JDRF Launches Center of Excellence to Accelerate Cure for Type 1 Diabetes

On September 4, JDRF announced the launch of its Northern California Center of Excellence, dedicated to focused efforts on research and breakthroughs to cure Type 1 diabetes.

Tandem’s Control-IQ Hybrid Closed Loop Approved by the FDA

The FDA announced the approval of the Control-IQ Hybrid Closed Loop System from Tandem Diabetes Care. The system sees the t:slim X2 insulin pump and Dexcom G6 continuous glucose monitor working together with help from Control-IQ's groundbreaking algorithm.

People With Diabetes Forgoing Basic Needs in Order to Survive According to New Studies

According to two studies presented at the American Association of Diabetes Educators 2019 Annual Conference, people with diabetes are forgoing basic needs in the face of rising healthcare costs and taking to underground exchanges of necessary supplies.

Nasal Glucagon Baqsimi Approved by the FDA

On Thursday, the Food and Drug Administration approved Eli Lilly and Company's Baqsimi, a non-injectable, nasal glucagon and the first of its kind.

Senate Bill Aims to Cut Price of Insulin by 75%

The "Insulin Price Reduction Act" would create a new pricing model for insulin, incentivizing manufacturers to lower list prices to 2006 prices.